+1 Recommend
1 collections
      • Record: found
      • Abstract: found
      • Article: found

      Effect of Epidermal Growth Factor on Sodium–Dependent L–Alanine Transport in LLC–PK1 Cells

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.


          We evaluated the role of epidermal growth factor (EGF) in the regulation of L–alanine transport in LLC–PK1 renal epithelia. After 2 h of incubation, EGF had no significant effect on L–alanine uptake by LLC–PK1 cells. However, prolonged (16 h) incubation with 2 and 20 ng/ml of EGF resulted in significant increases in sodium–dependent L–alanine uptake as compared with controls. Treatment with 12– O–tetradecanoylphorbol–13–acetate (TPA; 20 ng/ ml) caused a marked increase in sodium–dependent L–alanine uptake after both 2 and 16 h of incubation, and the treatment with TPA (20 ng/ml) EGF (20 ng/ml) for 16 h resulted in significant acceleration of the TPA–stimulated increase in L–alanine uptake by LLC–PK1 cells. Coincubation with H–7 (20 μ M) inhibited both EGF– and TPA–stimulated increases in L–alanine uptake, and genistein (20 μg/ml) blocked the stimulatory effect of EGF in L–alanine transport to the control level. Furthermore, coincubation with cycloheximide (20 μg/ml) for 16 h inhibited both EGF– and TPA–stimulated increases in L–alanine transport to a great extent. The sodium– independent L–alanine uptake was not affected by treatment with either EGF or TPA. These results suggest that the activation of protein kinase C through tyrosine kinase activation plays a role in the EGF effect of stimulating L–alanine transport in LLC–PK1 cells and that the effect is mainly due to increased protein de novo synthesis which occurs after protein kinase C activation.

          Related collections

          Author and article information

          Kidney Blood Press Res
          Kidney and Blood Pressure Research
          S. Karger AG
          15 October 1999
          : 23
          : 1
          : 10-13
          Department of Pediatrics, Kyoto Prefectural University of Medicine, Kyoto, Japan
          25948 Kidney Blood Press Res 2000;23:10–13
          © 1999 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          Page count
          Tables: 2, References: 21, Pages: 4
          Self URI (application/pdf):
          Original Paper


          Comment on this article